Servier UK
Debra Dotesio-Eyers is a seasoned professional in the pharmaceutical industry, currently serving as a Key Account Manager at Servier UK since November 2018. Dotesio-Eyers has previously held roles at PHARMA MAR LIMITED as a Medical Science Liaison, where responsibilities included resolving medical information requests and developing SOPs, and at PharmaMar as a Key Account Manager focused on promoting Trabectidin. Additional experience includes positions at Sinclair IS Pharma, Otsuka Pharmaceuticals, Pfizer UK Ltd, CEM Corporation, United Family Services, Harmony Labs, and Philip Analytical Services, encompassing sales, market access, technical support, and quality control. Dotesio-Eyers possesses a Bachelor of Science degree in Chemistry from Albright College and a Medical Technologist Certification from Saint Joseph Hospital School of Medical Technology.
This person is not in any teams
This person is not in any offices
Servier UK
1 followers
Servier is an international pharmaceutical company governed by a non-profit foundation with its headquarters in Suresnes (France). With a strong international presence in 149 countries and a turnover of 4.615 billion euros in 2019, Servier employs 22,000 people worldwide. Corporate growth is driven by Servier's constant search for innovation in five areas of excellence: cardiovascular diseases, diabetes, cancers, immune-inflammatory diseases, and neurodegenerative diseases, as well as by its activities in high-quality generic drugs. Being completely independent, the Group reinvests 25% of turnover (excluding generics) in research and development and uses all its profits for growth. Servier was created in 1954, and in 1964 Servier UK was the first subsidiary to open, with just two employees. To report a side effect with one of our products, please visit https://www.servier.co.uk/report-a-side-effect/ Reporting forms and information can also be found at www.mhra.gov.uk/yellowcard